Epirium Bio
epirium.com
Actively hiring
Health Care
Biologics & Biosimilars
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.
News
Piramal Pharma Solutions to Partner with Epirium Bio Pharmaceutical Technology
The collaboration includes an integrated program that encompasses formulation development, drug substances, and drug product manufacturing.
Read more
Report
Report
Epirium Bio Presented Positive Phase 1 Safety, Pharmacokinetics and Pharmacodynamics Data for MF-300, Supporting its Role in Muscle Health, as a Late-Breaker at the Gerontological Society of America Annual Scientific Meeting 2025
SAN DIEGO, November 17, 2025--Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, presented Phase 1 data for its lead candidate, MF-300, at the Gerontological Society of Ameri
Read more
Report
Star Tribune
Your source for Minnesota news today. Read articles, view photos or watch videos about news in Minneapolis, St. Paul, Duluth, St. Cloud, Rochester, and beyond.
Read more
Report
Pro access
Upgrade to see all 9 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.